CVS Health plans to split into two companies by 2028, but experts say the move may not resolve conflicts of interest between its insurance and PBM businesses. The post CVS Health Bids Goodbye to Vertical Integration But Not Conflict of Interest appeared first on MedCity News.

Acute kidney injury is a common and sometimes serious surgical complication. Researchers at New York’s Mount Sinai health system are building AI models to better predict who’s most at risk, so that healthcare providers can offer individualized, preventive care. The post Researchers Receive $4M NIH Grant to Build AI Model To Prevent  Kidney Injury  appeared first on MedCity News.

Servier’s sevasemten came from the acquisition of the muscular dystrophy assets of Edgewise Therapeutics. While the small molecule had met the goal of a Phase 2 test in Becker muscular dystrophy, Servier said new results in a pivotal cohort do not show statistically significant benefit. The post Servier Stumbles in Muscle Disease as Drug From $1.5B Deal Fails Pivotal Test appeared first on MedCity News.

To succeed, our healthcare system must fully embrace consumer-focused product design to address demands of scale, access, and daily usability that the market is revealing. The post When Patients Become Consumers: The New Care Stack Collides With Legacy Healthcare appeared first on MedCity News.

For all the pink ribbons we see, women with breast cancer are abandoning one of the most effective treatments they have because of symptoms no one in their care team is clearly responsible for. The post Breast Cancer Survivorship Is a Menopause Problem Nobody Owns appeared first on MedCity News.

The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its earlier letters to healthcare services companies about price transparency. The post The FTC Is Flexing Its Muscle in Healthcare appeared first on MedCity News.

Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera’s approach to drug R&D focuses on “causal intelligence,” which Flagship defines as predicting and understanding cause and effect in biology. The post Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines appeared first on MedCity News.

Rebuilding trust across a fragmented healthcare landscape demands that payers and providers alike move beyond transactional relationships and prioritize transparency, empathy, and tailored communication. The post Healthcare’s Trust Crisis Is an Experience Crisis appeared first on MedCity News.

The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase. The post Looser Health IT Certification Requirements Shift Oversight to Health Systems appeared first on MedCity News.

Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.

In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis. The post MedCity FemFwd: The Gaps in Endometriosis Care appeared first on MedCity News.

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage. The post Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor appeared first on MedCity News.

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed up the prior authorization process, and reduce healthcare spending. But a new report based on evidence recovered from a lawsuit raises concerns about the AI experiment. The post 7 Potential Problems with Medicare’s AI Prior Authorization Experiment  appeared first on MedCity News.

As health system dealmaking stays steady in 2026, Integris Health is joining Risant Health to accelerate value-based care. The partnership represents an integration of Risant Health’s capabilities into Integris’ existing system, rather than a traditional merger. The post Integris Health to Join Risant Health as Health System Dealmaking Stays Active appeared first on MedCity News.

Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient’s care? The post CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care appeared first on MedCity News.